BIO BIO-RAD LABORATORIES, INC.: institutional ownership and insider trading
432 funds reported holding $6.29B of BIO-RAD LABORATORIES, INC. in their latest 13F filings; in Q2 2026 funds net sold $158M, with 55 new positions and 52 funds selling out; over the last 12 months insiders bought $0 and sold $350K on the open market.
Famous investors holding BIO
- Izzy Englander (Millennium Management): $17.6M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $18.8M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $5.65M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $3.03M, 0.0% of the portfolio
Largest institutional holders of BIO
- First Eagle Investment Management, LLC — $765M
- VANGUARD GROUP INC — $538M
- BlackRock, Inc. (BLK) — $499M
- DIMENSIONAL FUND ADVISORS LP — $277M
- VANGUARD CAPITAL MANAGEMENT LLC — $243M
- ARIEL INVESTMENTS, LLC — $240M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $240M
- EARNEST PARTNERS LLC — $171M
- STATE STREET CORP (STT, STT-PG) — $168M
- BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BML-PG, BML-PH, BML-PJ, BML-PL) — $144M
Recent BIO insider trades
- May 11, 2026: Engelhardt Eva Anette sold 550 shares ($136K)
- Nov 6, 2025: Barry James sold 700 shares ($214K)
- Mar 14, 2025: Crowley Michael sold 3,000 shares ($741K)
5%+ owners
- Norman D. Schwartz: 97.2% (Schedule 13D/A, filed Oct 30, 2025)
- Alice N. Schwartz: 12.3% (Schedule 13D/A, filed Jul 18, 2025)
- First Eagle Investment Management, LLC: 11.4% (Schedule 13G/A, filed Aug 6, 2025)
- BlackRock, Inc.: 7.4% (Schedule 13G/A, filed Oct 17, 2025)